SCHEDULE OF WARRANTS ACTIVITY (Details) - $ / shares |
6 Months Ended | 12 Months Ended |
---|---|---|
Jun. 30, 2025 |
Dec. 31, 2024 |
|
Equity [Abstract] | ||
Number of Warrants, Outstanding Beginning | 38,107,500 | |
Weighted Average Exercise Price Outstanding Beginning | $ 0.16 | |
Weighted Average Remaining Contract Term (Year) | 3 years 2 months 1 day | |
Number of Warrants, Granted | ||
Weighted Average Exercise Price Warrants Granted | ||
Number of Warrants, Exercised | ||
Weighted Average Exercise Price Warrants Exercised | ||
Number of Warrants, Forfeit/Canceled | ||
Weighted Average Exercise Price Forfeit/Canceled | ||
Number of Warrants, Outstanding Ending | 38,107,500 | 38,107,500 |
Weighted Average Exercise Price Outstanding Ending | $ 0.16 | $ 0.16 |
Weighted Average Remaining Contract Term (Year) | 2 years 8 months 1 day | |
Number of Warrants, Exercisable Ending | 38,107,500 |
X | ||||||||||
- Definition The number of shares into which fully or partially vestednon-option equity outstanding as of the balance sheet date can be currently converted under the non-option equity plan. No definition available.
|
X | ||||||||||
- Definition Weighted average price at which non-option equity holders acquired shares when converting their non-option equity into shares. No definition available.
|
X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments expired in period weighted average exercise price. No definition available.
|
X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of non-option equity. No definition available.
|
X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock non-option equity plan. No definition available.
|
X | ||||||||||
- Definition Weighted average remaining contractual term for non-option equity awards outstanding No definition available.
|
X | ||||||||||
- Definition Weighted average remaining contractual term for non-option equity awards outstanding No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|